RxDoctor Payments Data

Rebekah Stallworth, APRN

Psychiatric/Mental Health · Pascagoula, MSNPI 1376157487

Payments from drug & device makers

$3,340in general payments, 2019–2025

Across 176 payments — averaging $18.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$386
  • Takeda Pharmaceuticals U.S.A., Inc.$345
  • Lundbeck LLC$342
  • Teva Pharmaceuticals USA, Inc.$258
  • Otsuka America Pharmaceutical, Inc.$244
  • plus $733 from 11 others

What the payments were for

  • Food & beverage$3,24897%
  • Education$923%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,340 in reported general payments places this provider in the 80th percentile of 486 psychiatric/mental health providers in Mississippi.

See all psychiatric/mental health providers in Mississippi

Medicare billing

Part B allowed, 2024
$15,846
Medicare patients
89
Services billed
215

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl18$46,299
RexultiBrexpiprazole11$16,924
Aripiprazole131$5,746
Duloxetine Hcl92$5,077
Oxcarbazepine59$1,849
Trazodone Hcl224$1,805
Divalproex Sodium ErDivalproex Sodium36$1,791
Buspirone Hcl167$1,478
Mirtazapine68$1,360
Bupropion XlBupropion Hcl75$1,307
Olanzapine59$1,186
Ziprasidone Hcl27$1,100
Hydroxyzine Hcl34$1,085
Quetiapine Fumarate ErQuetiapine Fumarate42$957
Fluoxetine Hcl93$857

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$1,032$46,29918 claims
Otsuka America Pharmaceutical, Inc.Rexulti$244$16,92411 claims
Almatica Pharma LLCSertraline Hcl$56$68187 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 486 psychiatric/mental health providers in Mississippi.

Other psychiatric/mental health in Pascagoula

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →